by The Johnson & Johnson campus in Zug © Keystone / Urs Flueeler American pharma group Johnson & Johnson (J&J) is to transfer four of its canton Neuchâtel-based subsidiaries to other locations – including abroad. The move is expected to result in the loss of up to 320 jobs by mid-2023. The company wants to move the production lines for its two of its subsidiaries in Neuchâtel, western Switzerland, to Puerto Rico and Mexico. The inspection and storage activities based at Marin will be transferred over to Selznach in canton Solothurn, a spokesman to the news agency AWP on Friday, confirming an announcement made on Thursday. The product line Ethicon Wound Closure & Repair Portfolio will cease. Overall up to 320 jobs are to be affected. A consultation process is
Topics:
Swissinfo considers the following as important: 3) Swiss Markets and News, 3.) Swiss Business and Economy, Featured, health, newsletter
This could be interesting, too:
Investec writes Swiss health care costs continued to rise in 2022
Investec writes Swiss parliament rejects adding dental care to basic insurance
Vibhu Vikramaditya writes Navigating the Slippery Slope: How Hoover’s Interventions Paved the Way for the Great Depression
Ryan McMaken writes Frédéric Bastiat Was a Radical Opponent of War and Militarism
The Johnson & Johnson campus in Zug © Keystone / Urs Flueeler
American pharma group Johnson & Johnson (J&J) is to transfer four of its canton Neuchâtel-based subsidiaries to other locations – including abroad. The move is expected to result in the loss of up to 320 jobs by mid-2023.
The company wants to move the production lines for its two of its subsidiaries in Neuchâtel, western Switzerland, to Puerto Rico and Mexico. The inspection and storage activities based at Marin will be transferred over to Selznach in canton Solothurn, a spokesman to the news agency AWP on Friday, confirming an announcement made on Thursday.
The product line Ethicon Wound Closure & Repair Portfolio will cease. Overall up to 320 jobs are to be affected.
A consultation process is currently taking place with the employees in Ethicon, Ethicon Women’s Health & Urology et Medos. A definitive decision on the final impact on employees will be taken after the consultation is over, the company said.
As only a few employees are affected at Medos International, no consultation is taking place at this subsidiary, it added.
The changes are expected to take place over the next few years, finishing by mid-2023.
Jean-Nathanaël Karakash, Neuchâtel minister in charge of the economy, said he was surprised and shocked by the news. He told local radio RTN that the authorities intended to open discussions on the move, Swiss public television RTS reportedExternal link.
J&J remains in Switzerland, the spokesman underlined. It currently employs 4,400 people here.
You Might Also Like
Rapid Covid-19 tests could offer a path back to normal
2020-09-26
Swiss pharmaceutical company Roche plans to launch a test that can detect the coronavirus in 15 minutes. Could tests like this become the norm?
Investors stake their money on postponing death
2020-10-04
A group of wealthy investors is gathering virtually in Switzerland to stake their money on a new asset class. It’s longevity, underpinned by the science and technology of longer and healthier lives, and it could be a multi-billion-dollar market.
How Vaccine Technology, Choice and Supply Work in Switzerland
2021-01-24
The Swiss Covid-19 vaccination campaign is up and running with two approved vaccines available to accelerate the fight against the virus, and others set to follow. How do the vaccine technologies work and compare, and can people choose which one they get?
Anti-corona protest planned later this month in Zurich
2020-08-23
After protests in May 2020, an eclectic group of anti-corona protestors is planning to protest against vaccines, masks and other measures aimed at limiting the spread of the virus on 29 August 2020 in Zurich, according to the newspaper Le Matin.
Confidence in vaccine safety remains low in Switzerland
2020-09-21
Compared to much of the world, confidence in the safety of vaccines is low in Switzerland, according to a recently published study. In 2015, only 30% of Swiss questioned strongly agreed that vaccines were safe, ranking it 133rd out of 149 nations in terms of confidence in vaccine safety.
Coronavirus: rapid tests prove reliable, according to Swiss study
2020-10-21
SARS-CoV-2 tests that give results in 15 minutes scored well on sensitivity, according to a study by Unisanté in Lausanne, Switzerland. The tests, which involve taking a sample of nasal secretions from the back of the nose and throat, test for a protein present in the virus.
Covid: Swiss becoming more skeptical of vaccines
2020-12-17
Mistrust of vaccines against Covid-19 continues to rise in Switzerland, according to a recently published survey.
Covid: Switzerland reaches 66,000 vaccinations against the virus
2021-01-16
Switzerland’s Federal Office of Public Health (FOPH) recently reported that 66,000 people in Switzerland had been vaccinated against the SARS-CoV-2 virus that causes Covid-19. The number was communicated by Nora Kronig of the FOPH during a press conference in Bern on Thursday 14 January 2020.
Tags: Featured,Health,newsletter